|Bid||0.0520 x 6579900|
|Ask||0.0590 x 10000000|
|Day's range||0.0530 - 0.0530|
|52-week range||0.0520 - 0.2000|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||N/A|
|Earnings date||29 Sept 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Invictus Ops Pty Ltd, a wholly owned subsidiary of NSX-listed VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has contracted Resonance Health Ltd (ASX:RHT) to provide liver-fat quantification services for its clinical study on a potential new treatment for Non-Alcoholic Steatohepatitis.
It is hard to get excited after looking at Resonance Health's (ASX:RHT) recent performance, when its stock has declined...